Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Libin Liu

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
European Journal of Nutrition|February 21, 2020
A negative association between urinary iodine concentration and the prevalence of hyperuricemia and gout: a cross-sectional and population-based study in Mainland ChinaXixuan Lu, Xiaoguang Shi, Yanbo Li, et al.
Frontiers in Endocrinology|June 14, 2021
Hyperthyroidism Prevalence in China After Universal Salt IodizationChuyuan Wang, Yongze Li, Di Teng, et al.
Frontiers in Endocrinology|April 8, 2020
The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National SurveyJinjia Zhang, Yiyang Gao, Yongze Li, et al.
BMJ (Clinical Research Ed.)|April 30, 2020
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional studyYongze Li, Di Teng, Xiaoguang Shi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 21, 2020
Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland ChinaYongze Li, Di Teng, Jianming Ba, et al.
Journal of Medicinal Chemistry|August 6, 2019
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.
Thyroid : Official Journal of the American Thyroid Association|March 20, 2020
U-Shaped Associations Between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional StudyMingyue Jin, Zhuo Zhang, Yongze Li, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry|April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry|July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS PenetrationJason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
European Journal of Nutrition|February 21, 2020
A negative association between urinary iodine concentration and the prevalence of hyperuricemia and gout: a cross-sectional and population-based study in Mainland ChinaXixuan Lu, Xiaoguang Shi, Yanbo Li, et al.
Frontiers in Endocrinology|June 14, 2021
Hyperthyroidism Prevalence in China After Universal Salt IodizationChuyuan Wang, Yongze Li, Di Teng, et al.
Frontiers in Endocrinology|April 8, 2020
The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National SurveyJinjia Zhang, Yiyang Gao, Yongze Li, et al.
BMJ (Clinical Research Ed.)|April 30, 2020
Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional studyYongze Li, Di Teng, Xiaoguang Shi, et al.
Thyroid : Official Journal of the American Thyroid Association|February 21, 2020
Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland ChinaYongze Li, Di Teng, Jianming Ba, et al.
Journal of Medicinal Chemistry|August 6, 2019
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseYunhang Guo, Ye Liu, Nan Hu, et al.
Thyroid : Official Journal of the American Thyroid Association|March 20, 2020
U-Shaped Associations Between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional StudyMingyue Jin, Zhuo Zhang, Yongze Li, et al.
Journal of Medicinal Chemistry|February 6, 2020
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry|April 26, 2022
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS<sup>G12C</sup>Jason G Kettle, Sharan K Bagal, Sue Bickerton, et al.
Journal of Medicinal Chemistry|July 3, 2023
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRAS<sup>G12C</sup> with Demonstrable CNS PenetrationJason G Kettle, Sharan K Bagal, Derek Barratt, et al.
Pageof 21